+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Inducing dyskinesia in MPTP-treated common marmosets The effects of repeated treatment with combinations of L-dopa and ropinirole



Inducing dyskinesia in MPTP-treated common marmosets The effects of repeated treatment with combinations of L-dopa and ropinirole



Neurology 50(4 Suppl. 4): A135




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031900394

Download citation: RISBibTeXText


Related references

Effects of repeated treatment with combinations of L-DOPA and ropinirole on dyskinesia induction in MPTP-treated common marmosets. British Journal of Pharmacology 123(PROC Suppl. ): 252P, 1998

Effects of repeated treatment with L-DOPA, bromocriptine and ropinirole in drug naive MPTP-treated common marmosets. British Journal of Pharmacology 118(PROC Suppl. JULY): 37P, 1996

A comparison of ropinirole, L-dopa, and bromocriptine treatment on the development of dyskinesia in MPTP-treated common marmosets. Neurology 48(3 Suppl. 2): A119, 1997

Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets. Neuroscience 115(4): 1047-1058, 16 December, 2002

Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets. Experimental Neurology 204(1): 162-170, 2007

Comparison of repeated treatment with L-DOPA, pergolide and apomorphine on dyskinesia induction in MPTP-treated common marmosets. British Journal of Pharmacology 125(PROC Suppl. ): 4P, 1998

The ability of ropinirole to reverse L-dopa-induces dyskinesia in MPTP-treated marmosets. European Journal of Neurology 10(Suppl. 1): 19, 2003

Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation. Movement Disorders 17(5): 887-901, 2002

Differential effects of ropinirole, bromocriptine and L-DOPA on striatal dopamine D-2 receptor binding in MPTP-treated common marmosets. British Journal of Pharmacology 122(PROC Suppl. ): 315P, 1997

Differential effects of ropinirole, bromocriptine and L-Dopa on striatal preproenkephalin and preprotachykinin mRNA expression in MPTP-treated common marmosets. British Journal of Pharmacology 122(PROC Suppl. ): 161P, 1997

Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus). Movement Disorders 16(4): 631-641, 2001

Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets. Experimental Neurology 211(1): 172-179, 2008

Effects of central and peripheral cholinergic drugs on locomotor activity and L-DOPA-induced dyskinesia in MPTP-treated common marmosets. British Journal of Pharmacology 119(PROC Suppl. ): 29P, 1996

GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets. European Journal of Neuroscience 13(3): 597-608, 2001

Continuous rotigotine administration reduces dyskinesia resulting from pulsatile treatment with rotigotine or L-DOPA in MPTP-treated common marmosets. Experimental Neurology 221(1): 79-85, 2010